0000000001236591

AUTHOR

F. Marchetti

showing 14 related works from this author

Metabolic disorders across hepatocellular carcinoma in Italy

2018

Background: Metabolic disorders are well-known risk factors for HCC. Conversely, their impact on the natural history of HCC is not established. This study aimed at evaluating the impact of metabolic disorders on clinical features, treatment and survival of HCC patients regardless of its aetiology. Methods: We analysed the ITA.LI.CA database regarding 839 HCC patients prospectively collected. The following metabolic features were analysed: BMI, diabetes, arterial hypertension, hypercholesterolaemia and hypertriglyceridaemia. According to these features, patients were divided into 3 groups: 0-1, 2 and 3-5 metabolic features. Results: As compared with patients with 0-1 metabolic features, pati…

OncologyMaleobesityDatabases FactualHepatocellular carcinoma0302 clinical medicineRisk FactorsProspective cohort studydiabetesMetabolic disorderLiver NeoplasmsDiabeteshepatocellular carcinomaMiddle AgedMetabolic syndromePortal vein thrombosisItaly030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyFemalemedicine.medical_specialtyCarcinoma HepatocellularSettore MED/12 - GASTROENTEROLOGIADiabetes; Hepatocellular carcinoma; Metabolic syndrome; Obesitymetabolic syndrome03 medical and health sciencesDatabasesMetabolic DiseasesInternal medicinemedicineDiabetes MellitusHumansObesityFactualAgedNeoplasm StagingRetrospective StudiesHepatologybusiness.industryCarcinomaHepatocellularHepatologymedicine.diseaseSurvival AnalysisBCLC Stagediabetes; hepatocellular carcinoma; metabolic syndrome; obesity; Aged; Carcinoma Hepatocellular; Databases Factual; Diabetes Mellitus; Female; Humans; Italy; Liver Neoplasms; Male; Metabolic Diseases; Middle Aged; Multivariate Analysis; Neoplasm Staging; Obesity; Retrospective Studies; Risk Factors; Survival AnalysisdiabeteMultivariate AnalysisLiver functionMetabolic syndromebusiness
researchProduct

The changing scenario of hepatocellular carcinoma in Italy: an update

2021

Background and aims: Epidemiology of hepatocellular carcinoma (HCC) is changing in most areas of the world. This study aimed at updating the changing scenario of aetiology, clinical presentation, management and prognosis of HCC in Italy during the last 15 years. Methods: Retrospective analysis of the Italian Liver Cancer (ITA.LI.CA) database included 6034 HCC patients managed in 23 centres from 2004 to 2018. Patients were divided into three groups according to the date of cancer diagnosis (2004-2008, 2009-2013 and 2014-2018). Results: The main results were: (i) a progressive patient ageing; (ii) a progressive increase of non-viral cases and, particularly, of ‘metabolic’ and ‘metabolic + alc…

medicine.medical_specialtyPediatricsCarcinoma HepatocellularRadiofrequency ablationmedicine.medical_treatmentSettore MED/12 - GASTROENTEROLOGIAsurvivalepidemiology; hepatocellular carcinoma; survival; treatment; Humans; Italy; Neoplasm Staging; Retrospective Studies; Carcinoma Hepatocellular; Liver Neoplasmslaw.invention03 medical and health sciences0302 clinical medicinelawRetrospective StudieEpidemiologyMedicineHumansNeoplasm StagingRetrospective StudiesHepatologytreatmentbusiness.industryLiver NeoplasmsCarcinomaSettore MED/09 - MEDICINA INTERNACancerHepatocellularhepatocellular carcinomamedicine.diseaseCalendar periodItaly030220 oncology & carcinogenesisHepatocellular carcinomaEtiologyepidemiology; hepatocellular carcinoma; survival; treatment030211 gastroenterology & hepatologyepidemiologyPercutaneous ethanol injectionbusinessLiver cancer
researchProduct

Validación de los datos de radiación solar UV del Ozone Monitoring Instrument (OMI) a partir de medidas con base en tierra en la costa mediterránea

2016

<p align="justify">The erythemal UV daily dose (EDD) and the local noon UV Index (UVI) obtained from the Ozone Monitoring Instrument (OMI), on board NASA’s Aura satellite, have been validated for the period 2005-2013 using ground based measurements at 5 different sites in the Mediterranean coast: Murcia, Valencia, Palma de Mallorca, Barcelona and Rome (where only measurements of the local noon UVI were available). Ground based measurements were made using YES UVB-1 radiometers in Murcia, Valencia, Palma de Mallorca and Barcelona, and a Brewer MKIV 067 spectrophotometer in Rome. The results of the validation showed good agreement between the satellite instrument and the ground based me…

Dosis Eritemática DiariaOzone Monitoring Instrument010504 meteorology & atmospheric sciencesradiación solar UVGeography Planning and DevelopmentOzone Monitoring Instrumentlcsh:G1-922010502 geochemistry & geophysics01 natural sciencesÍndice UVGeographyEarth and Planetary Sciences (miscellaneous)radiación solar UV; Índice UV; Dosis Eritemática Diaria; Ozone Monitoring Instrument.HumanitiesCartographylcsh:Geography (General)0105 earth and related environmental sciences
researchProduct

Syinthesis and spectroscopic and X-ray structural Characterization of R2Sn(IV)-Oxydiacetate and -Iminoacetate complexes

2005

researchProduct

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer

2019

There is no sufficient evidence to establish a standard of care for patients with brain metastases (BM) from HER2Data of 154 patients were retrospectively collected at 14 Italian institutions through a specifically designed database.Median overall survival (OS) was 24.5 months. Patients receiving surgery/stereotactic radiosurgery experienced longer OS compared to those receiving whole-brain radiotherapy or no treatment (33.5 vs. 11.4 months; hazard ratio = 0.34; 95% confidence interval, 0.22-0.52; P .001). Interestingly, whole-brain radiotherapy did not improve OS compared to no treatment (11.4 vs. 9.8 months; hazard ratio = 0.99; 95% confidence interval, 0.62-1.62; P = .99). HER2-targeted …

Adult0301 basic medicineCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSocio-culturaleBreast NeoplasmsLapatinibTreatment experiencedRadiosurgerySRS03 medical and health sciences0302 clinical medicineBreast cancerTrastuzumabInternal medicineHER2 Positive Breast CancerBiomarkers TumormedicineHumansAgedRetrospective Studiesbusiness.industryLapatinibTrastuzumabMiddle AgedWBRTPrognosismedicine.diseaseCombined Modality TherapyConfidence intervalSurvival RateRadiation therapyLapatinib SRS Surgery Trastuzumab WBRT030104 developmental biologyReceptors EstrogenOncology030220 oncology & carcinogenesisLapatinib; SRS; Surgery; Trastuzumab; WBRTSurgeryFemaleNeoplasm Recurrence LocalbusinessFollow-Up Studiesmedicine.drugClinical Breast Cancer
researchProduct

Nd:YVO4 crystalline film grown by pulsed laser deposition

2009

Abstract We present the preliminary results obtained in the growth of thin films of Nd-doped YVO4 (YVO) by pulsed laser deposition (PLD) on amorphous substrate. The films were obtained by ablating bulk YVO crystals doped with Nd3+ ions with a Q-switched tripled Nd:YAG laser in a UHV chamber. The samples have been characterized both morphologically (with X-ray diffraction and atomic force microscope measurements) and spectroscopically, by measuring fluorescence spectra and lifetime.

Materials sciencePhotoluminescenceRare-heart doped oxideOrganic ChemistryDopingAnalytical chemistryPulsed laser depositionSubstrate (electronics)LaserSettore ING-INF/01 - ElettronicaQ-switchingAtomic and Molecular Physics and OpticsNanostructuresElectronic Optical and Magnetic MaterialsPulsed laser depositionlaw.inventionAmorphous solidInorganic ChemistrylawElectrical and Electronic EngineeringPhysical and Theoretical ChemistryThin filmSpectroscopyOptical Materials
researchProduct

The HERBA trial: a retrospective study on patients (pts) with HER2-positive (HER2+ve) breast cancer (BC) and brain metastases (BMs)

2017

GynecologyOncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicinemedicineRetrospective cohort studyHematologymedicine.diseasebusinessER2-positive (HER2+ve) breast cancer (BC) brain metastases (BMs)
researchProduct

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020

2020

Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day–17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.

MalePediatricsEpidemiologyProtease InhibitorComorbiditymedicine.disease_causeClinical Laboratory TechniqueSevere Acute Respiratory SyndromeDisease OutbreaksFeces0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticaCOVID-19 TestingRetrospective StudiePandemic030212 general & internal medicineViralChildCoronavirusPediatricDisease OutbreakCoinfectionHospitals PediatricSettore MED/38HospitalsDiarrheaTreatment OutcomeSARS-CoV-2 infection; children; covid-19; hydroxychloroquine; pneumonia; Adolescent; Antiviral Agents; Betacoronavirus; COVID-19; COVID-19 Testing; Child; Child Preschool; Chronic Disease; Clinical Laboratory Techniques; Coinfection; Comorbidity; Coronavirus; Coronavirus Infections; Diarrhea; Disease Outbreaks; Feces; Female; Fever; Hospitals Pediatric; Humans; Immunocompromised Host; Infant; Infant Newborn; Italy; Male; Noninvasive Ventilation; Pandemics; Pneumonia Viral; Protease Inhibitors; Retrospective Studies; SARS-CoV-2; Severe Acute Respiratory Syndrome; Treatment OutcomeItalyChild PreschoolCoinfectionFemalemedicine.symptomCoronavirus InfectionsRapid CommunicationHumanDiarrheamedicine.medical_specialtyCOVID-19; ItalyhydroxychloroquineAdolescentFeverCoronaviruPneumonia ViralAntiviral Agents03 medical and health sciencesBetacoronavirusImmunocompromised Hostchildren030225 pediatricsVirologyIntensive caremedicineHumanspneumoniaProtease InhibitorsPreschoolPandemicsRetrospective StudiesAntiviral Agentchildren; covid-19; hydroxychloroquine; pneumonia; SARS-CoV-2 infection; Adolescent; Antiviral Agents; Betacoronavirus; Child; Child Preschool; Chronic Disease; Clinical Laboratory Techniques; Coinfection; Comorbidity; Coronavirus; Coronavirus Infections; Diarrhea; Disease Outbreaks; Feces; Female; Fever; Hospitals Pediatric; Humans; Immunocompromised Host; Infant; Infant Newborn; Italy; Male; Noninvasive Ventilation; Pandemics; Pneumonia Viral; Protease Inhibitors; Retrospective Studies; Severe Acute Respiratory Syndrome; Treatment OutcomeNoninvasive VentilationBetacoronaviruPandemicbusiness.industryClinical Laboratory TechniquesCoronavirus InfectionSARS-CoV-2pneumonia.SARS-CoV-2 infectionPublic Health Environmental and Occupational HealthInfant NewbornCOVID-19InfantRetrospective cohort studymedicine.diseaseNewbornComorbidityCoronavirusPneumoniaChronic DiseaseFecebusiness
researchProduct

Pattern of macrovascular invasion in hepatocellular carcinoma

2021

Background and aims: In patients with hepatocellular carcinoma (HCC), macrovascular invasion (MaVI) limits treatment options and decreases survival. Detailed data on the relationship between MaVI extension and patients' characteristics, and its impact on patients' outcome are limited. We evaluated the prevalence and extension of MaVI in a large cohort of consecutive HCC patients, analysing its association with liver disease and tumour characteristics, as well as with treatments performed and patients' survival. Methods: We analysed data of 4774 patients diagnosed with HCC recorded in the Italian Liver Cancer (ITA.LI.CA) database (2008-2018). Recursive partition analysis (RPA) was performed …

Ablation TechniquesMaleRegistrieCirrhosisClinical BiochemistryMesenteric Veinloco-regional treatment030204 cardiovascular system & hematologyBiochemistryGastroenterologysurgeryAntineoplastic AgentLiver disease0302 clinical medicineNon-alcoholic Fatty Liver Diseasecirrhosis; hepatocellular carcinoma; loco-regional treatment; portal vein thrombosis; surgery; transplantationAscitesAblation Techniqueportal vein thrombosisRegistries030212 general & internal medicineChronicSettore MED/12 - GastroenterologiaPortal VeinLiver DiseasesLiver NeoplasmsAsciteshepatocellular carcinomaGeneral MedicineMiddle AgedSorafenibPrognosisHepatitis BAlcoholicHepatitis CTumor BurdenSurvival RateItalyLiver NeoplasmHepatocellular carcinomaAsciteFemalemedicine.symptomLiver cancerHumanmedicine.medical_specialtyCarcinoma HepatocellularPrognosiAntineoplastic AgentsEnd Stage Liver Disease03 medical and health sciencesMesenteric VeinsHepatitis B ChronicInternal medicinemedicineHumansHepatectomyNeoplasm Invasivenessportal vein thrombosiLiver Diseases AlcoholicAgedNeoplasm Invasivene...Performance statusbusiness.industrycirrhosisCarcinomaSettore MED/09 - MEDICINA INTERNAPatient AcuityHepatocellularHepatitis C Chronicmedicine.diseaseLiver TransplantationTransplantationLiver functionbusinesscirrhositransplantationEuropean Journal of Clinical Investigation
researchProduct

CCDC 179596: Experimental Crystal Structure Determination

2004

Related Article: H.Jankovics, C.Pettinari, F.Marchetti, E.Kamu, L.Nagy, S.Troyanov, L.Pellerito|2003|J.Inorg.Biochem.|97|370|doi:10.1016/S0162-0134(03)00309-X

Space GroupCrystallographyCrystal Systemcatena-((N-((S)-3-Mercapto-2-methylpropionyl)-L-proline)-dimethyl-tin(iv))Crystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 233991: Experimental Crystal Structure Determination

2005

Related Article: C.Pettinari, F.Marchetti, R.Pettinari, A.Cingolani, E.Rivarola, C.Phillips, J.Tanski, M.Rossi, F.Caruso|2004|Eur.J.Inorg.Chem.||3484|doi:10.1002/ejic.200400225

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinatessyn-bis(3-Methyl-1-phenyl-4-pivaloyl-5-pyrazolonato-OO')-lead(ii)
researchProduct

CCDC 233990: Experimental Crystal Structure Determination

2005

Related Article: C.Pettinari, F.Marchetti, R.Pettinari, A.Cingolani, E.Rivarola, C.Phillips, J.Tanski, M.Rossi, F.Caruso|2004|Eur.J.Inorg.Chem.||3484|doi:10.1002/ejic.200400225

anti-bis(3-Methyl-1-phenyl-4-(phenylacetyl)-5-pyrazolonato-OO')-tin(ii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 233992: Experimental Crystal Structure Determination

2005

Related Article: C.Pettinari, F.Marchetti, R.Pettinari, A.Cingolani, E.Rivarola, C.Phillips, J.Tanski, M.Rossi, F.Caruso|2004|Eur.J.Inorg.Chem.||3484|doi:10.1002/ejic.200400225

Space GroupCrystallographysyn-bis(3-Methyl-1-phenyl-4-(t-butylacetyl)-5-pyrazolonato-OO')-lead(ii)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 258719: Experimental Crystal Structure Determination

2005

Related Article: F.Marchetti, M.Pellei, C.Pettinari, R.Pettinari, E.Rivarola, C.Santini, B.W.Skelton, A.H.White|2005|J.Organomet.Chem.|690|1878|doi:10.1016/j.jorganchem.2005.01.067

Space GroupCrystallographyfac-(bis(35-Dimethylpyrazolyl)acetato-NN'O)-tris(iodo)-tin(iv) acetonitrile solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct